One of their most recent publications is Early Contrast Enhancement: A novel magnetic resonance imaging biomarker of pleural malignancy. Which was published in journal Lung Cancer.

More information about Selina Tsim research including statistics on their citations can be found on their Copernicus Academic profile page.

Early Contrast Enhancement: A novel magnetic resonance imaging biomarker of pleural malignancy

Highlights•A novel MRI biomarker of pleural malignancy is described – Early Contrast Enhancement.•Early Contrast Enhancement is a semi-objective, perfusion-based biomarker.•Early Contrast Enhancement can be measured in patients with minimal pleural thickening.

Baseline predictors of negative and incomplete pleural cytology in patients with suspected pleural malignancy – Data supporting ‘Direct to LAT’ in selected groups

Highlights•Asbestos exposure is an independent predictor of negative pleural fluid cytology.•A malignant CT is an independent predictor of negative pleural fluid cytology.•Failure of predictive marker testing in pleural fluid is common in ovarian cancer.•Negative pleural fluid cytology is associated with an increased time to diagnosis.